Effective and Safe Glycemic Control in Patients with Diabetes Mellitus Type 2 when Using Fixed Combination of Oral Hypoglycemic Agents

Effective and Safe Glycemic Control in Patients with Diabetes Mellitus Type 2 when Using Fixed Combination of Oral Hypoglycemic Agents

Diabetes mellitus (DM) type 2 is associated not only with hyperglycemia, but also with an increased atherogenic risk. Due to this glucose-lowering therapy should be not only effective, but also safe regarding the development of micro- and macrovascular complications. To intensify hypoglycemic therap...

Full description

Bibliographic Details
Main Author:	V.I. Pankiv
Format:	Article
Language:	English
Published:	Zaslavsky O.Yu. 2013-05-01
Series:	Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:	diabetes mellitus type 2 diabetes metformin glibenclamide a fixed combination
Online Access:	http://iej.zaslavsky.com.ua/article/view/84378

Similar Items

Novel Activity of Oral Hypoglycemic Agents Linked with Decreased Formation of Tryptophan Metabolite, Kynurenic Acid
by: Kinga Bednarz, et al.
Published: (2024-01-01)

Oral anti-diabetics for gestational diabetes mellitus – where do we stand?
by: Delia Cudalba, et al.
Published: (2020-09-01)

Determination of structural properties in the adsorption of drugs on chitosan-hydrogels for type 2 diabetes by means of the PM6 method
by: Nancy Liliana Delgadillo Armendariz, et al.
Published: (2020-05-01)

Step-by-step Individual Intensification of Therapy for Type 2 Diabetes Mellitus. What is Further Choice after Metformin? (Literature Review)
by: І.V. Pankiv
Published: (2015-03-01)

Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients
by: Hassan M. Al-Temimi, et al.
Published: (2017-03-01)

Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports
by: Manoj Chawla, et al.
Published: (2023-03-01)

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
by: Hayes J, et al.
Published: (2016-07-01)

Type 2 diabetes mellitus: current international guidelines, personalized approach and real outpatient practice
by: V.I. Pankiv
Published: (2020-09-01)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
by: Moses R
Published: (2010-05-01)

Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
by: Rebecca M. Reynolds, et al.
Published: (2017-09-01)

Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel
by: Sanjay Kalra, et al.
Published: (2020-01-01)

Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment
by: M. V. Shestakova, et al.
Published: (2021-07-01)

In vitro α–amylase inhibitory activity and in vivo hypoglycemic effect of methanol extract of Citrus macroptera Montr. fruit
by: Nizam Uddin, et al.
Published: (2014-06-01)

Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model
by: Marianne Berdugo, et al.
Published: (2021-07-01)

REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY"
by: A. A. Aleksandrov
Published: (2016-01-01)

EFFECT OF DOUBLE HYPOGLYCEMIC THERAPY WITH METFORMIN AND SAXAGLIPTIN, ON ACHIEVEMENT OF GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND ADJUVANT OBESITY
by: Liliia Nikulina
Published: (2018-09-01)

Hypoglycemic and in vitro antioxidant activities of Stereospermum kunthianum stem bark hydromethanol extract
by: Julius O. ODE, et al.
Published: (2022-09-01)

Anti-diabetic effect of Capparis spinosa L. root extract in diabetic rats
by: Mostafa Kazemian Mansur Abad, et al.
Published: (2015-06-01)

Comparative effects of oral hypoglycemic drugs on serum YKL-40 level in type 2 diabetic patients.
by: Caterine N. Matta*, et al.
Published: (2020-07-01)

Early treatment of neonatal diabetes with oral glibenclamide in an extremely preterm infant
by: Alfonso Galderisi, et al.
Published: (2023-03-01)

Management of type 2 diabetes mellitus: selecting the right of antihyperglycemic medication
by: E. V. Biryukova
Published: (2018-03-01)

Hypoglycemic agents and potential anti-inflammatory activity
by: Kothari V, et al.
Published: (2016-04-01)

Metformin versus insulin in the management of gestational diabetes mellitus
by: Ola Amer Mahmood
Published: (2019-01-01)

Combined Therapy with Antihyperglycemic Oral Agents (Metformin, Sulfonylureas) and Insulin in the Management of Type 2 Diabetic Patients (Pathogenic Substantiation and Clinical Utility)
by: M.Yu. Horshunskaia
Published: (2015-05-01)

Hypoglycemic and antioxidant effects of leaf essential oil of <it>Pelargonium graveolens</it> L’Hér. in alloxan induced diabetic rats
by: Boukhris Maher, et al.
Published: (2012-06-01)

Glibenclamide therapy: pros and cons
by: Olga Konstantinovna Vikulova, et al.
Published: (2011-09-01)

A Comparative Investigation of the Effects of the Cynara scolymus L. and Glibenclamide on Biochemical Parameters in Diabetic Rats
by: Hossein Poorcheraghi, et al.
Published: (2019-09-01)

Investigation of anti-diabetic potential of Diodia sarmentosa in alloxan-induced diabetic albino rats
by: Ijomone Oghogho Rosalie, et al.
Published: (2018-03-01)

Hypoglycemic and hypolipidemic effects of ethanolic and aqueous extracts from Ziziphus oenoplia (L) Mill on alloxan-induced diabetic rats
by: Pramod Mourya, et al.
Published: (2017-03-01)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
by: Miriam Méndez-del Villar, et al.
Published: (2017-02-01)

Efficacy and safety of hypoglycemic agents on gestational diabetes mellitus in women: A Bayesian network analysis of randomized controlled trials
by: Ting Wang, et al.
Published: (2022-12-01)

Glycemic Control Potential of Chemically Characterized Extract from <i>Withania frutescens</i> L. Roots in Severe Diabetes-Induced Mice
by: Abdelfattah El Moussaoui, et al.
Published: (2021-04-01)

Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects
by: Goak IS, et al.
Published: (2022-12-01)

Eeffect of the hydroalcolic Lavandula stoechas L. extract in Comparison Glibenclamide on blood glucose in streptozotocin induced diabetic male rats
by: zahra abolghasemi, et al.
Published: (2017-05-01)

Comparison of glibenclamide and insulin on neonatal outcomes in pregnant women with gestational diabetes
by: Mitra Behrashi, et al.
Published: (2016-01-01)

Anti-Hyperglycemic and Hypoglycemic Activities of 80% Methanol Extract and Solvent Fractions of Ocimum lamiifolium Hochst Ex Benth. (Lamiaceae) Leaves in Mice
by: Tesfaye T, et al.
Published: (2023-06-01)

Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital
by: Chia‐Po Fu, et al.
Published: (2021-09-01)

Motor dysfunction of gastric antral smooth muscle in diabetic rats: Contribution of ATP-dependent potassium channels
by: Fatameh Khoshavi Najafabadi, et al.
Published: (2023-01-01)

Quercetin reduce cardiomyocytes damage in type 2 diabetic rats
by: Asri Hendrawati, et al.
Published: (2014-12-01)

In vitro and in vivo Antidiabetic Properties of Phenolic Antioxidants From Sedum adenotrichum
by: Dil Naz, et al.
Published: (2019-11-01)